Jennifer Champoux's most recent trade in Monte Rosa Therapeutics Inc was a trade of 135,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 2, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Monte Rosa Therapeutics Inc | Jennifer Champoux | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 135,000 | 135,000 | - | - | Stock Option (Right to Buy) | |
| Monte Rosa Therapeutics Inc | Jennifer Champoux | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 30,000 | 30,000 | - | - | Common Stock | |
| Monte Rosa Therapeutics Inc | Jennifer Champoux | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) |